Motor neuron disease and amyotrophic lateral sclerosis

Motor neuron disease and amyotrophic lateral sclerosis

In this post we’ll break down the major types of MNDs, compare their clinical features and highlight points crucial for competitive exams like NEET PG, INI-CET, and FMGE. Core issue is combination of UMN and LMN lesion findings coexistent in a same patient for ALS. Physicist Stephen hawking was the longest living survivor of this fatal disorder that ultimately causes demise due to diaphragmatic paralysis. As bonus tip learn differences between AIDP and CIDP in 2 minutes at the bottom of this article.

Comparison of Major Motor Neuron Disease 

Disease UMN involvement LMN involvement Key features Onset & Progression Age of Onset Prognosis 
Amyotrophic lateral Sclerosis (ALS)Mixed signs: spasticity + fasciculations; bulbar signs commonGradual onset, relentless progression40-70 yearsFatal within 3-5 years ( respiratory failure)
Primary Lateral Sclerosis XPure UMN signs: spasticity, hyperreflexia, Babinski sign: no fasciculationsVery slow progression>50 yearsRelatively benign
Progressive muscular Atrophy (PMA)XPure LMN signs; muscle wasting, fasciculations, flaccid weaknessGradual30-60 yearsBetter than ALS but can evolve into ALS
Spinal muscular Atrophy (SMA)XSymmetrical LMN weakness, hypotonia, tongue fasciculations (esp. in infants)Depends on type (infantile to adult)Infancy to adulthoodVaries (SMA type I is fatal in infancy)
Progressive Bulbar Palsy √ (bulbar UMNs)√ (bulbar LMNs)Dysarthria, dysphagia, tongue atrophy, emotional labilityOften progresses to ALS40-70 yearsPoor
Pseudobulbar Palsy XDysarthria, dysphagia, emotional lability, but no tongue wasting or fasciculationsOften associated with bilateral stroked / MSOlder adultsVariable

 

Key Clinical Differences 

  1. ALS (Amyotrophic lateral sclerosis)
  • Hallmark: Combination of UMN and LMN signs in multiple regions
  • Buzzwords: Fasciculations + spasticity: tongue atrophy; split hand sign

  1. PLS (Primary Lateral Sclerosis) 
  • Hallmark: Pure UMN involvement
  • Clue: No Fasciculations or muscle wasting
  1. PMA ( Progressive Muscular Atrophy
  • Hallmark: Pure LMN disease
  • Buzzwords: Muscle atrophy, areflexia, fasciculations, no spasticity
  • May progress to ALS over time.
  1. SMA (Spinal Muscular Atrophy) 
  • Genetics: Autosomal recessive, SMN1 gene mutation
  • Types:
  • Type I (Werdnig-Hoffmann): Infantile, floppy baby, fatal in 1st year
  • Type II: Childhood onset
  • Type III: (Kugelberg-Welander): Adolescent / adult onset
  • Type: IV: Adult form, mildest

 

  1. Progressive Bulbar Palsy Vs Pseudobulbar Palsy 
  2. Feature Progressive Bulbar Pseudobulbar 
    SiteCN IX – XII (LMN)UMN to bulbar nuclei
    TongueAtrophy, fasciculations Small spastic, no atrophy
    ReflexesAbsent gag reflexExaggerated jaw jerk
    Emotional labilityPresentPresent
    AssociationMay be variant of ALSOften bilateral strokes /MS

     

    Important Exam Points 

    • Most common MND: ALS
    • ALS Affects both UMN and LMN – a key distinguishing feature
    • Fasciculations + spasticity: Think ALS
    • Tongue fasciculations in infants: Think SMA type I
    • No sensory involvement is typical in MNDs.
    • Frontotemporal dementia may coexist with ALS (especially C9 or F72 mutation)
    • Riluzole is the only FDA – approval drug for ALS – prolongs survival by ~3 months.

    Recent Advances 

    1. Risdiplam for SMA
    • Type: Oral SMN2 splicing modifier
    • Mechanism: Increases production of functional SMN protein via enhanced SMN2 splicing
    • Route: Oral syrup taken daily
    • Age: Approved for infants (>2 months), children, and adult
    1. Gene therapy for SMA (Type I) with nusinersen and onasemnogene abeparvovec has revolutionized prognosis in children.
    2. Edaravone has been added as a treatment option in some ALS cases.

     

    Bonus Tip 

    Comparison: AIDP vs CIDP

    FeatureAIDP (Acute Inflammatory Demyelinating Polyradiculoneuropathy)CIDP (chronic Inflammatory Demyelinating Polyradiculoneuropathy) 
    Full form Acute inflammatory demyelinating polyradiculoneuropathyChronic Inflammatory Demyelinating Polyradiculoneuropathy
    Type Most common variant of GBSChronic form
    OnsetAcute (subtype of GBS)Chronic (≥ weeks)
    Progression Rapid (Similar to GBS)Slowly progressive or relapsing
    WeaknessAscending symmetricSimilar but slower, often proximal and distal
    Reflexes Absent or decreasedAbsent or decreased
    CSFSame as GBSSame ( mildly elevated protein, low WBC)
    Nerve Conduction DemyelinatingDemyelinating
    Treatment IVIG or plasmapheresisSteroids IVIG, plasmapheresis (long -term)

     

Leave a reply